Limited Time: Receive 30% off your first treatment
Get StartedOsteoarthritis (OA) is a leading cause of joint pain, stiffness, and reduced mobility, affecting millions of people worldwide. Traditional treatments—such as pain medications, corticosteroid injections, and joint replacement surgery—often focus on symptom management rather than addressing the root cause: cartilage degeneration. Fortunately, regenerative medicine offers a revolutionary alternative that promotes natural healing and tissue repair.
Unlike conventional approaches, regenerative therapies harness the body’s innate healing mechanisms to repair damaged cartilage, reduce inflammation, and restore joint function. The key lies in mesenchymal stem cells (MSCs), which release growth factors, cytokines, and exosomes that:
Suppress chronic inflammation (a major driver of OA progression).
Stimulate cartilage regeneration by activating native repair cells.
Protect remaining joint tissue from further breakdown.
Improve joint lubrication and mobility over time.
These effects are achieved through minimally invasive injections, avoiding the risks and lengthy recovery of surgery.
Regenerative medicine is particularly effective for:
Early to moderate knee osteoarthritis (before severe joint damage occurs).
Post-traumatic joint degeneration (e.g., after sports injuries or accidents).
Active individuals seeking to delay or avoid joint replacement.
Patients unresponsive to steroids, physical therapy, or NSAIDs.
Non-Surgical & Minimally Invasive – No incisions, general anesthesia, or hospital stays.
Targets the Underlying Problem – Promotes actual tissue repair, not just pain masking.
Faster Recovery – Most patients resume light activities within days.
Long-Term Results – Slows disease progression and may prevent future surgeries.
Clinical studies support the efficacy of MSC-based treatments:
A 2023 study in the International Journal of Molecular Sciences found that umbilical-derived MSCs significantly improved cartilage thickness and collagen levels in large animal models.
A 2025 randomized controlled trial (PMC11775978) demonstrated that bone marrow-derived MSCs reduced pain and preserved cartilage in human patients over 12 months.
If you’re seeking an advanced, science-backed alternative to joint replacement, regenerative therapies may provide the solution. At Total PRP Clinic, our San Diego specialists customize treatments using the latest evidence-based protocols.
Take the Next Step: Contact us today to explore whether regenerative medicine can restore your joint health—naturally and without surgery.